• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用阵列研究ATP结合盒转运蛋白在癌症化疗耐药性中的作用及化疗敏感性预测。

Use of arrays to investigate the contribution of ATP-binding cassette transporters to drug resistance in cancer chemotherapy and prediction of chemosensitivity.

作者信息

Zhang Jian-Ting

机构信息

Department of Pharmacology and Toxicology, Walther Oncology Center/Walther Cancer Institute and IU Cancer Center, Indiana University School of Medicine, 1044 W. Walnut Street, R4-166, Indianapolis, IN 46202, USA.

出版信息

Cell Res. 2007 Apr;17(4):311-23. doi: 10.1038/cr.2007.15.

DOI:10.1038/cr.2007.15
PMID:17404598
Abstract

Multidrug resistance (MDR) is a major problem in cancer chemotherapy. One of the best known mechanisms of MDR is the elevated expression of ATP-binding cassette (ABC) transporters. While some members of human ABC transporters have been shown to cause drug resistance with elevated expression, it is not yet known whether the over-expression of other members could also contribute to drug resistance in many model cancer cell lines and clinics. The recent development of microarrays and quantitative PCR arrays for expression profiling analysis of ABC transporters has helped address these issues. In this article, various arrays with limited or full list of ABC transporter genes and their use in identifying ABC transporter genes in drug resistance and chemo-sensitivity prediction will be reviewed.

摘要

多药耐药(MDR)是癌症化疗中的一个主要问题。MDR最广为人知的机制之一是ATP结合盒(ABC)转运蛋白的表达升高。虽然已表明人类ABC转运蛋白的一些成员在表达升高时会导致耐药,但在许多模型癌细胞系和临床中,其他成员的过表达是否也会导致耐药尚不清楚。用于ABC转运蛋白表达谱分析的微阵列和定量PCR阵列的最新发展有助于解决这些问题。本文将综述具有有限或完整ABC转运蛋白基因列表的各种阵列及其在识别耐药和化疗敏感性预测中的ABC转运蛋白基因方面的应用。

相似文献

1
Use of arrays to investigate the contribution of ATP-binding cassette transporters to drug resistance in cancer chemotherapy and prediction of chemosensitivity.利用阵列研究ATP结合盒转运蛋白在癌症化疗耐药性中的作用及化疗敏感性预测。
Cell Res. 2007 Apr;17(4):311-23. doi: 10.1038/cr.2007.15.
2
Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance.赋予多药耐药性的小鼠ATP结合盒(ABC)转运蛋白
Anticancer Agents Med Chem. 2015;15(4):423-32.
3
Expression profiling of ABC transporters in a drug-resistant breast cancer cell line using AmpArray.使用AmpArray对耐药乳腺癌细胞系中ABC转运蛋白进行表达谱分析。
Mol Pharmacol. 2005 Aug;68(2):430-8. doi: 10.1124/mol.105.011015. Epub 2005 May 18.
4
Methylation of miR-129-5p CpG island modulates multi-drug resistance in gastric cancer by targeting ABC transporters.miR-129-5p CpG岛的甲基化通过靶向ABC转运蛋白调节胃癌中的多药耐药性。
Oncotarget. 2014 Nov 30;5(22):11552-63. doi: 10.18632/oncotarget.2594.
5
Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes.基于微阵列通过ATP结合盒转运蛋白基因表达谱检测人类肿瘤细胞中的多药耐药性
Cancer Res. 2004 Dec 15;64(24):8987-93. doi: 10.1158/0008-5472.CAN-04-1978.
6
Advances in the molecular detection of ABC transporters involved in multidrug resistance in cancer.癌症多药耐药相关 ABC 转运蛋白的分子检测进展。
Curr Pharm Biotechnol. 2011 Apr;12(4):686-92. doi: 10.2174/138920111795163931.
7
Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells.预测药物敏感性和耐药性:分析癌细胞中的ABC转运蛋白基因
Cancer Cell. 2004 Aug;6(2):129-37. doi: 10.1016/j.ccr.2004.06.026.
8
[Advances in the targeting ATP-binding cassette transporters to overcome tumor multi-drug resistance].靶向ATP结合盒转运蛋白以克服肿瘤多药耐药性的研究进展
Yao Xue Xue Bao. 2010 Oct;45(10):1205-11.
9
Reversing agents for ATP-binding cassette drug transporters.ATP结合盒式药物转运体的逆转剂
Methods Mol Biol. 2010;596:325-40. doi: 10.1007/978-1-60761-416-6_14.
10
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade.哺乳动物 ABC 家族药物外排转运蛋白在多药耐药中的作用:过去十年的回顾。
Cancer Lett. 2016 Jan 1;370(1):153-64. doi: 10.1016/j.canlet.2015.10.010. Epub 2015 Oct 20.

引用本文的文献

1
MiR-548c-3p through suppressing and increases the sensitivity of colorectal cancer cells to 5-fluorouracil.MiR-548c-3p通过抑制……并增加结肠癌细胞对5-氟尿嘧啶的敏感性。 (原文中“suppressing”后缺少具体内容)
Heliyon. 2023 Nov 5;9(11):e21775. doi: 10.1016/j.heliyon.2023.e21775. eCollection 2023 Nov.
2
Are active efflux transporters contributing to infant drug exposure via breastmilk? A longitudinal study.主动外排转运蛋白是否通过母乳导致婴儿药物暴露?一项纵向研究。
Basic Clin Pharmacol Toxicol. 2022 Dec;131(6):487-499. doi: 10.1111/bcpt.13794. Epub 2022 Oct 6.
3
Phenotypic Consequences of Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer.
高级别浆液性卵巢癌中融合现象超出耐药性的表型后果
Cancers (Basel). 2021 Nov 11;13(22):5644. doi: 10.3390/cancers13225644.
4
Targeting Drug Chemo-Resistance in Cancer Using Natural Products.利用天然产物靶向治疗癌症的化疗耐药性。
Biomedicines. 2021 Sep 29;9(10):1353. doi: 10.3390/biomedicines9101353.
5
Deficiency in Dipeptidyl Peptidase-4 Promotes Chemoresistance through the CXCL12/CXCR4/mTOR/TGFβ Signaling Pathway in Breast Cancer Cells.二肽基肽酶-4 缺乏通过 CXCL12/CXCR4/mTOR/TGFβ 信号通路促进乳腺癌细胞的化疗耐药性。
Int J Mol Sci. 2020 Jan 26;21(3):805. doi: 10.3390/ijms21030805.
6
The Emerging Role of the SLCO1B3 Protein in Cancer Resistance.溶质载体有机阴离子转运体家族1成员B3(SLCO1B3)蛋白在癌症抵抗中的新作用。
Protein Pept Lett. 2020;27(1):17-29. doi: 10.2174/0929866526666190926154248.
7
Development of precision medicine approaches based on inter-individual variability of BCRP/.基于乳腺癌耐药蛋白个体间变异性的精准医学方法的发展。
Acta Pharm Sin B. 2019 Jul;9(4):659-674. doi: 10.1016/j.apsb.2019.01.007. Epub 2019 Jan 15.
8
FoxM1 Induced Paclitaxel Resistance via Activation of the FoxM1/PHB1/RAF-MEK-ERK Pathway and Enhancement of the ABCA2 Transporter.FoxM1通过激活FoxM1/PHB1/RAF-MEK-ERK信号通路及增强ABCA2转运蛋白诱导紫杉醇耐药。
Mol Ther Oncolytics. 2019 May 21;14:196-212. doi: 10.1016/j.omto.2019.05.005. eCollection 2019 Sep 27.
9
Guided chemotherapy based on patient-derived mini-xenograft models improves survival of gallbladder carcinoma patients.基于患者来源的微小异种移植模型的引导化疗可改善胆囊癌患者的生存。
Cancer Commun (Lond). 2018 Jul 17;38(1):48. doi: 10.1186/s40880-018-0318-8.
10
Interaction of WBP2 with ERα increases doxorubicin resistance of breast cancer cells by modulating MDR1 transcription.WBP2 与 ERα 的相互作用通过调节 MDR1 转录增加乳腺癌细胞对阿霉素的耐药性。
Br J Cancer. 2018 May 1;119(2):182-192. doi: 10.1038/s41416-018-0119-5.